PASS is an analysis solution optimized for academia and pharma research. The proprietary solution was derived from proven technology and innovation embedded in Mastocheck, a proteomics-based early cancer diagnostics approved by Ministry of Food and Drug Safety (MFDS).
Bertis developed the PASS solution based on its pan-omics, bioinformatics, and artificial intelligence (AI) technologies. We provide a variety of analyzes for proteomic analysis, biomarker discovery and verification, new drug development, clinical process development, etc.
PASS is a platform for integrative analysis of pan-omics data, based on our proven and reliable bioinformatics analysis capabilities. Our team consists of experienced scientists with an extensive track record of research achievements spanning more than a decade in mass spectrometry-based proteomics.
Bertis possesses the core expertise and proprietary technology for pan-omics (multi-omics) analysis to provide customized solutions in all fields where omics data analysis is applicable.
With PASS, you can leverage Bertis scientific resources and cutting-edge tools to advance your research projects and goals, from the design stage to the interpretation and visualization of bioinformatics analysis results.
Proteomics-based Early diagnosis using multiple markers provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests.
Early diagnostic solutions
BERTIS has commercialized MASTOCHECK, the worlds first proteomics-based blood test solution for early diagnosis of breast cancer, and clinical trials are being conducted on biomarkers for various cancers. Ultimately, these technologies are being used to continually expand the pipeline to allow dozens of diseases to be diagnosed with a single blood test.
Biomarker Diseases Diagnosis Blood Tests
Proteomics-based early diagnosis Provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests.
Advantages of proteomics-based early diagnosis:
Proteomics-based early diagnosis determines the presence of disease by identifying proteins that are specifically expressed in diseases and using these as biomarkers to measure the quantitative values of the relevant proteins in blood.
Proteomics analysis has been assessed as highly likely to be used as a universal primary screening method because analysis can be performed even with trace samples, such as a few drops of blood.
PC-PASS Protein Characterization Analysis
Protein Characterization (Physicochemical property of proteins) structure analysis using mass spectrometry provides results that meet the requirements of the FDA, the MFDS and other regulatory authorities regarding novel therapies or biosimilars. Based on basic amino acid analysis (full sequencing), we perform post-translational modification (PTM) analysis, which is important for protein potency and stability. In this regard, we can perform test methods based on design of experiment (DOE) statistical methodology and deliver documents to be submitted to regulatory authorities.
Protein identification and quantification : Structural analysis of all types of protein therapeutics, including monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), and enzymes
- Full Length-Amino acids sequencing Peptide identification of each peak through peptide mapping (MS spectrum confirmation, MS/MS spectral analysis with 100% AA matches)
- Improved N- and C-terminal sequencing of proteins
Post-translational modification (PTM) : More reliable results based on design of experiment (DOE) statistical methodology to perform the experiments systematically and analyze data efficiently
- Disulfide bond analysis ID Total possible lankage analysis
- Deamidation identification and quantification
- Phosphorylation identification and quantification , phospho-proteomic analysis
- Other functional modifications
Glycomics : Single protein analysis and research of protein complexes with glycosylation closely related to biological function and toxicity as well as structural stability of proteins
- Glycosylation site determination
- Glycan profiling
- Site-specific glycan identification and quantification
- Glycomics research with glycan enrichment
Bulk Screening Tests for COVID, Flu, and other Respiratory Diseases on Smartphones using AI Technology
Quantity Available: UNLIMITED
Pricing: As low as $0.50 per test
Product Website: RTVoiceTest.com
Business Registration Website: RTNAccount.com
The Real Time Voice Analyzer (RTVA) is an advanced AI screening app for Apple and Android smartphones that utilizes voice biomarkers and AI algorithms to detect airborne respiratory viruses, including COVID-19 and its variants and even some strains of influenza and the common cold. The RTVA app is Fast, Accurate, and Non-Invasive, and free to download. For more information and a Free Trial (no credit card needed), please visit:
RTVoiceTest.com
We offer bulk discounts on screening tests to large companies and organizations. With pricing as low as $0.50 per test, and UNLIMITED TESTING, the RTVA is ideal for large to very large groups. For more information, please contact:
5094 Diagnostic Kits Suppliers
Short on time? Let Diagnostic Kits sellers contact you.
Corona test kit from South Korea. Approval by FDA, CE, FSC.
Kits have been exported to Europe, North America, South America, etc.
Price : EXW KOREA and US$ 15
MOQ : 1,000Kits(can be used for 100,000cases)
Payment Terms : T/T 100% In advance.
Delivery : Contacted DHL.
Production : within a week.
User have to equip RT-PCR. We need to check which one you have.
hCG Pregnancy Rapid Test is an one step highly sensitive test kit for the determination of HCG (Human Chorionic Gonadotropin) in human urine and/or serum/plasma. It is used to obtain a visual, qualitative results for early detection of pregnancy.
Human Chorionic Gonadotropin (hCG) is a glycoprotein hormone produced by the developing placenta shortly after fertilization, including protein subunits of �± and �². Its function is to stimulate the corpus luteum to continue producing progesterone, to maintain the endometrium is suitable for embryo attachment and embryo implantation.
One step, rapid immunochromatographic assay for detectionof NS1Ag of all serotypes of Dengue virus in human serum orplasmaDetection of infection prior to sero - conversionDetects all serotypes (DEN-1,DEN-2,DEN-3, DEN-4)Specimen volume : 90 - 100 ul of Serum/PlasmaNo sample preparation requiredResult interpretation time: 20 minsSensitivity :> 95%. Specificity : =95%
his kit adopts the method of indirect competitive enzyme-linked immunoassay (ELISA) to detect Tylosin (TYL) in the sample such as poultry tissue, honey.
Specification 96wells per kit
This kit adopts the method of indirect competitive enzyme-linked immunoassay (ELISA) to detect Aflatoxin B1 (AFB1) in the sample such as grains and feed.
This kit adopts the method of indirect competitive enzyme-linked immunoassay (ELISA) to detect Nitroimidazoles (NMZ) in the sample such as tissue, honey and eggs.
Our products related to Bovine disease detection mainly include the following
Zearalenone (ZON/ZEN) ELISA Kit Aflatoxin B1 (AFB1) ELISA Kit
Deoxynivalenol � (DON) ELISA Kit Aflatoxin M1 (AFM1) ELISA Kit
Total Aflatoxin � (AFT) ELISA Kit T2 Toxin (T2) ELISA Kit
Fumonisin B1 � (FB1) ELISA Kit Ochratoxin A (OTA) ELISA Kit
Shenzhen Finder Biotech Co., Ltd. is a a high-tech enterprise located in Shenzhen, China. Our company is engaged in rapid detection of food safety (such as residue detection of veterinary drugs, additives, hormones, mycotoxins), rapid diagnosis of animal diseases and related product development. There are hundreds of products. Secondly, the diagnostic kits and test cards for animal diseases mainly for livestock and poultry have been widely used in Animal Husbandry Government Department, scientific research institutions and universities, which provides a strong basis and guarantee for monitoring immunity and diagnosis.
PRODUCT DESCRIPTION
The machine specify diameter and mass ball fall on the foam specimen from certain height, calculate the percentage between maximum drop height and rebound height, indicate foam resilience by spring rate. It uses a microprocessor to control, LCD display.
GENERL SPECIFICATIONS
Packaging Dimensions: (WxDxH) 680*470*860mm
Power supply source: single-phase, AC220V�±10%, 50/60Hz (can be appointed)
Gross Weight: 40kg
APPLICATION STANDARDS:
ASTM D 3574, ISO 8307, SEC N3296
STANDARD FEATURES
Drop height 500±0.5%mm
Drop ball Diameter: 16±0.05 mm, mass 16.8g ± 1.5 g
Accuracy
